By Tina Reed
"As we increase vaccinations and can envision the end of the pandemic and its economic effects, we believe it is the right time to restart this project that was paused nearly a year ago," officials said in a statement.
read more
By Angus Liu
New COVID-19 drugs such as Gilead Sciences’ remdesivir have their limitations, so scientists continue to look for ways to repurpose existing medicines as quick solutions to the pandemic. Now, an international team has promising data in hamsters showing that an old leprosy drug, clofazimine, may help fight the coronavirus.
read more
By Robert King
Providence supply chain executive Brad Alexander shares how the system's supply chain changed one year after the onset of the pandemic.
read more
By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale
AstraZeneca's shot fell far short against a South African virus variant, a study found. Pfizer will likely raise its vaccine price tag once the pandemic subsides. Catalent is ramping up capacity at its Anagni, Italy plant. States are rapidly expanding vaccine access in the U.S. And France and Italy may soon resume vaccinations with AZ's shot.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
By Kevin Dunleavy
Catalent has seized many opportunities to be a major player in the COVID-19 pandemic fight. Now, the CDMO plans to expand its plant in Anagni, Italy, doubling its capacity there to produce vaccines for Johnson & Johnson.
read more
By Paige Minemyer
Policymakers should build upon the foundation of the newly-minted COVID-19 relief package to continue improving access to coverage, according to experts at the Robert Wood Johnson Foundation.
read more
